Interactions on record — worth a quick check against your medications. Check your meds →
Dietary supplement

Mood Probiotic Ingredients & Drug Interactions

by InnovixLabs

Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Mood Probiotic is a dietary supplement by InnovixLabs with 2 active ingredients. Its ingredients are commonly taken for digestive health and regularity, irritable bowel syndrome (ibs), diarrhea (including antibiotic-related).Based on those ingredients, 182 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Bifidobacterium longum Rosell-175, Lactobacillus helveticus Rosell-52 ND. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Mood Probiotic by InnovixLabs

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 0 of its 2 active ingredients.
  • “Mood Probiotic Blend” is a proprietary blend — the label doesn't break down how much of each component you get.

Mood Probiotic contains two active ingredients: Bifidobacterium longum Rosell-175 and Lactobacillus helveticus Rosell-52 ND. Both are live, beneficial bacteria strains designed to support your gut microbiome.

The product also contains inactive ingredients — potato starch, hydroxypropyl methylcellulose, and magnesium stearate — which are standard capsule fillers and binders.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use.

Why this rating?
  • The label markets this product for: mood and stress support.
  • We looked for evidence on: Depression, Generalized anxiety disorder (GAD), Anxiety, Emotional well-being.
  • The closest evidence on file: Bifidobacterium Longum is rated "Insufficient Reliable Evidence To Rate" for Generalized anxiety disorder (GAD) (Natural Medicines).
  • Also on file: Bifidobacterium Longum is rated "Insufficient Reliable Evidence To Rate" for Depression.
  • Also on file: Lactobacillus Helveticus is rated "Insufficient Reliable Evidence To Rate" for Depression.

The evidence we hold shows insufficient reliable data to rate either of these probiotic strains for the conditions they're marketed to support — including mood and cognitive function, anxiety, allergic rhinitis, antibiotic-associated diarrhea, and athletic performance. That doesn't mean they don't work; it means rigorous clinical trials haven't established their benefit yet for these uses.

Talk with your pharmacist about what the emerging research suggests if you're considering this product.

The evidence, ingredient by ingredient Bifidobacterium Longum Lactobacillus Helveticus

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Both strains are generally well tolerated in healthy people. However, if you're seriously ill, immunocompromised, or critically ill, these products require extra caution — there have been rare but serious reports of these bacteria entering the bloodstream (bacteremia or sepsis) in vulnerable patients, especially premature infants and those on life support.

Oral side effects are rare and may include abdominal discomfort, bloating, flatulence, or constipation. One patient reported a dry cough.

Safety data during breastfeeding are limited, so check with your doctor before use if you're nursing. For pregnancy, the data are rated possibly safe, but discuss with your healthcare provider for personalized guidance.

Side effects, ingredient by ingredient Bifidobacterium Longum Lactobacillus Helveticus

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 2 of the 2 matched ingredients can interact with medications — Bifidobacterium Longum, Lactobacillus Helveticus.
  • The most serious interaction on file is rated Moderate.
  • For scale: 182 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

If you take antibiotic drugs, separate them from this product — antibiotics can reduce the probiotic's effectiveness by killing the live organisms. Ask your pharmacist for the best timing.

No other drug interactions are documented for the ingredients we checked.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with no established evidence rating for its marketed use. Moderate medication interactions have been identified, and safety information is well characterized.

If you're a healthy adult with no serious illness or immune problems, this product is an option to explore — though the evidence for its mood and cognitive benefits isn't yet established. If you're on antibiotics, space them away from this product.

If you're critically ill, immunocompromised, pregnant, or breastfeeding, talk to your doctor or pharmacist before starting.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 2 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Sep 25, 2025.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Mood Probiotic, straight from the product label.

Brand InnovixLabs
Barcode (UPC) X000SNDSGD
Net contents 60 Capsule(s)
Market status On market
Date entered into DSLD Sep 25, 2025
DSLD ID 334986
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years), Gluten Free, Sugar Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Mood Probiotic by InnovixLabs, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container
60
UPC/BARCODE
X000SNDSGD
IngredientAmount% DV
Mood Probiotic Blend0 NP--
Bifidobacterium longum Rosell-1750 NP--
Lactobacillus helveticus Rosell-52 ND0 NP--

Other ingredients: Potato Starch, Hydroxypropyl Methylcellulose, Magnesium Stearate

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Storage

Storage: Store in a cool (75 degrees F or below), dry place. Avoid exposure to high heat and/or moisture.

Storage and handling conditions can affect number of live cultures. Store under recommended conditions. Refrigeration may help maintain high bacteria count.

Formulation

Does not contain: eggs, corn, fish, shellfish, tree nuts, peanuts, wheat/gluten, sugar, GMO, yeast, Chinese ingredients, artificial colors, or flavors.

Time for effect: In clinical studies, those who noticed an effect required a month of regular use. Individual results may vary.

Based on clinical research Mood support supplement May help ease physical and psychological symptoms of stress May help support positive mood balance

Source: Probiotics are cultivated and encapsulated in Canada. Packaged and tested in USA.

Precautions

Allergy information: May contain trace amounts of soy and milk used in the fermentation process. Made in a facility and processed on shared equipment that handles dairy, soy, and gluten. Individuals extremely sensitive to these ingredients should consult a physician prior to using this product.

Warning: If you are pregnant, nursing, or taking any other supplements or medications, talk to your doctor before use.

Not recommended for use by people under the age of 18. Keep out of reach of children.

If you experience any adverse reaction, discontinue use and contact your doctor.

General Statements

New

FDA Statement of Identity

Dietary Supplement

Suggested/Recommended/Usage/Directions

Suggested use: Take 1-2 capsules per day with a meal.

Brand IP Statement(s)

Copyright 2021 Innovix Pharma Inc. All rights reserved.

See for yourself

Mood Probiotic by InnovixLabs label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Mood Probiotic by InnovixLabs

These are the 2 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Capsule(s) Dosage formCapsule Servings per container60 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Mood Probiotic Blend

0 NP per serving

Other (inactive) ingredients: Potato Starch, Hydroxypropyl Methylcellulose, Magnesium Stearate. These complete the product’s ingredient list but are not active constituents.

Interaction report

Mood Probiotic by InnovixLabs Drug Interactions

Want to check YOUR meds against Mood Probiotic?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
182Drugs
182 Moderate

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in Mood Probiotic with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Bifidobacterium longum Rosell-1751 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Bifidobacterium longum with antibiotic drugs might decrease the effectiveness of B. longum.
Since B. longum preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. longum preparations by at least 2 hours.

Likelihood Probable Evidence D

Lactobacillus helveticus Rosell-52 ND1 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Lactobacillus helveticus with antibiotic drugs might decrease the effectiveness of L. helveticus.
Lactobacillus helveticus preparations usually contain live and active organisms. Therefore, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and L. helveticus preparations by at least two hours.

Likelihood Probable Evidence D
The maker

Brand information

Manufacturer and brand details for Mood Probiotic, from the product label.

InnovixLabs

See all InnovixLabs products
Name
InnovixLabs - A Division of Innovix Pharma Inc.
City
Calabasas
State
CA
ZipCode
91302
Phone Number
888-799-7627
Web Address
www.innovixlabs.com
Pharmacist Counseling Corner

Mood Probiotic by InnovixLabs: Common Questions

Does Mood Probiotic by InnovixLabs interact with any medications?
Yes. Based on its ingredients, Mood Probiotic has a known interaction with 182 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Mood Probiotic contains 2 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Can I take this while I'm on antibiotics?
Not at the same time. Since the probiotics are living bacteria, antibiotics will kill them and reduce the product's effectiveness. Space them apart — your pharmacist can help you figure out the best schedule for your specific antibiotic.
Is this safe if I'm pregnant or breastfeeding?
For pregnancy, the data support it as possibly safe — but talk with your doctor or midwife first for personalized advice. For breastfeeding, the safety data are limited, so check with your doctor before use.
Does this actually help with mood and anxiety?
The evidence we hold is insufficient to rate it reliably for mood, anxiety, or cognitive function. Research is ongoing, but clinical proof isn't established yet. Ask your pharmacist about the latest studies if you're curious.
What side effects should I watch for?
Side effects are rare. You might experience mild abdominal discomfort, bloating, or flatulence — these are not uncommon when starting probiotics. One person reported a dry cough. If you're seriously ill or immunocompromised, the risk of a serious infection from the live bacteria is higher, so use only under medical guidance.
Is there anything else in this besides the probiotics?
The capsule contains standard inactive ingredients: potato starch, hydroxypropyl methylcellulose, and magnesium stearate — all common binders and fillers.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Mood Probiotic is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Mood Probiotic label
Sources

Sources & How We Checked

Mood Probiotic's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 23 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Bifidobacterium Longum 21 references
  1. Ha GY, Yang CH, Kim H, Chong Y. Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol 1999;37:1227-8.
  2. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  3. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
  4. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130(6):1355-60. PubMed
  5. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
  6. Pellonperä O, Vahlberg T, Mokkala K, et al. Weight gain and body composition during pregnancy: a randomised pilot trial with probiotics and/or fish oil. Br J Nutr. 2020 Nov 4:1-11. PubMed
  7. Pellonperä O, Mokkala K, Houttu N, et al. Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: A randomized, placebo-controlled, double-blind clinical trial PubMed
  8. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  9. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
  10. Enomoto T, Sowa M, Nishimori K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int 2014;63(4):575-85. PubMed
  11. US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
  12. Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259. PubMed
  13. Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022;28(7):732-744.
  14. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52(11) PubMed
  15. Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.
  16. Tamaki H, Nakase H, Inoue S, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Dig Endosc 2016;28(1):67-74.
  17. Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7. PubMed
  18. Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis 2016;22(9):1664-6.
  19. Tena D, Losa C, Medina MJ, Sáez-Nieto JA. Peritonitis caused by Bifidobacterium longum: case report and literature review. Anaerobe 2014;27:27-30. PubMed
  20. Sangkanjanavanich S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, Boonpiyathad T. Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial. Ann Allergy Asthma Immunol 2022;129(6):790-792. PubMed
  21. Wilson HL, Ong CW. Bifidobacterium longum vertebrodiscitis in a patient with cirrhosis and prostate cancer. Anaerobe 2017;47:47-50. PubMed

See these in context on the Bifidobacterium Longum monograph →

Lactobacillus Helveticus 2 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed

See these in context on the Lactobacillus Helveticus monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring